Registro:

Referencias:

• Barondes, S.H., Castronovo, V., Cooper, D.N., Cummings, R.D., Drickamer, K., Feizi, T., Galectins: a family of animal beta-galactoside-binding lectins (1994) Cell, 76 (4 FEBRUARY), pp. 597-598
• Barondes, S.H., Cooper, D.N., Gitt, M.A., Leffler, H., Galectins. Structure and function of a large family of animal lectins (1994) Journal of Biological Chemistry, 269 (33 AUGUST), pp. 20807-20810
• Rabinovich, G.A., Toscano, M.A., Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation (2009) Nature Reviews Immunology, 9 (5 MAY), pp. 338-352
• Leffler, H., Galectins structure and function - a synopsis (2001) Results and Problems in Cell Differentiation, 33, pp. 57-83
• Cummings, R.D., Liu, F.-T., Galectins (2009) Essentials of Glycobiology, pp. 475-487. , PB - Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY), A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart, M.E. Etzler (Eds.)
• Leffler, H., Carlsson, S., Hedlund, M., Qian, Y., Poirier, F., Introduction to galectins (2004) Glycoconjugate Journal, 19 (7-9), pp. 433-440
• Elola, M.T., Chiesa, M.E., Alberti, A.F., Mordoh, J., Fink, N.E., Galectin-1 receptors in different cell types (2005) Journal of Biomedical Science, 12 (1), pp. 13-29
• Camby, I., Le Mercier, M., Lefranc, F., Kiss, R., Galectin-1: a small protein with major functions (2006) Glycobiology, 16 (11 NOVEMBER), pp. 137R-157R
• Dumic, J., Dabelic, S., Flogel, M., Galectin-3: an open-ended story (2006) Biochimica et Biophysica Acta, 1760 (4 JANUARY), pp. 616-635
• Cueni, L.N., Detmar, M., Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions (2009) Experimental Cell Research, 315 (10 JUNE), pp. 1715-1723
• Wiersma, V.R., de Bruyn, M., Helfrich, W., Bremer, E., Therapeutic potential of galectin-9 in human disease (2011) Medicinal Research Reviews, (JULY)
• Surolia, A., Swaminathan, C.P., Ramkumar, R., Podder, S.K., Unusual structural stability and ligand induced alterations in oligomerization of a galectin (1997) FEBS Letters, 409 (3 JUNE), pp. 417-420
• Miyanishi, N., Nishi, N., Abe, H., Kashio, Y., Shinonaga, R., Nakakita, S., Carbohydrate-recognition domains of galectin-9 are involved in intermolecular interaction with galectin-9 itself and other members of the galectin family (2007) Glycobiology, 17 (4 APRIL), pp. 423-432
• Earl, L.A., Bi, S., Baum, L.G., Galectin multimerization and lattice formation are regulated by linker region structure (2011) Glycobiology, 21 (1 JANUARY), pp. 6-12
• Garner, O.B., Baum, L.G., Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling (2008) Biochemical Society Transactions, 36 (DECEMBER), pp. 1472-1477. , (Pt 6)
• Rabinovich, G.A., Toscano, M.A., Jackson, S.S., Vasta, G.R., Functions of cell surface galectin-glycoprotein lattices (2007) Current Opinion in Structural Biology, 17 (5 OCTOBER), pp. 513-520
• Liu, F.T., Patterson, R.J., Wang, J.L., Intracellular functions of galectins (2002) Biochimica et Biophysica Acta, 1572 (2-3 SEPTEMBER), pp. 263-273
• Haudek, K.C., Spronk, K.J., Voss, P.G., Patterson, R.J., Wang, J.L., Arnoys, E.J., Dynamics of galectin-3 in the nucleus and cytoplasm (2010) Biochimica et Biophysica Acta, 1800 (2 FEBRUARY), pp. 181-189
• Lame, M.W., Jones, A.D., Wilson, D.W., Segall, H.J., Monocrotaline pyrrole targets proteins with and without cysteine residues in the cytosol and membranes of human pulmonary artery endothelial cells (2005) Proteomics, 5 (17 NOVEMBER), pp. 4398-4413
• Krishnan, V., Bane, S.M., Kawle, P.D., Naresh, K.N., Kalraiya, R.D., Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium (2005) Clinical and Experimental Metastasis, 22 (1), pp. 11-24
• Rabinovich, G.A., Galectin-1 as a potential cancer target (2005) British Journal of Cancer, 92 (7 APRIL), pp. 1188-1192
• Rabinovich, G.A., Cumashi, A., Bianco, G.A., Ciavardelli, D., Iurisci, I., D'Egidio, M., Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis (2006) Glycobiology, 16 (3 MARCH), pp. 210-220
• Thijssen, V.L., Postel, R., Brandwijk, R.J., Dings, R.P., Nesmelova, I., Satijn, S., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proceedings of the National Academy of Sciences of the United States of America, 103 (43 OCTOBER), pp. 15975-15980
• Ryschich, E., Lizdenis, P., Ittrich, C., Benner, A., Stahl, S., Hamann, A., Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma (2006) Cancer Research, 66 (1 JANUARY), pp. 198-211
• Furuhata, S., Ando, K., Oki, M., Aoki, K., Ohnishi, S., Aoyagi, K., Gene expression profiles of endothelial progenitor cells by oligonucleotide microarray analysis (2007) Molecular and Cellular Biochemistry, 298 (1-2 APRIL), pp. 125-138
• Thijssen, V.L., Barkan, B., Shoji, H., Aries, I.M., Mathieu, V., Deltour, L., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Research, 70 (15 AUGUST), pp. 6216-6224
• Dias-Baruffi, M., Stowell, S.R., Song, S.C., Arthur, C.M., Cho, M., Rodrigues, L.C., Differential expression of immunomodulatory galectin-1 in peripheral leukocytes and adult tissues and its cytosolic organization in striated muscle (2010) Glycobiology, 20 (5 MAY), pp. 507-520
• Bidon-Wagner, N., Le Pennec, J.P., Human galectin-8 isoforms and cancer (2004) Glycoconjugate Journal, 19 (7-9), pp. 557-563
• Spitzenberger, F., Graessler, J., Schroeder, H.E., Molecular and functional characterization of galectin 9 mrna isoforms in porcine and human cells and tissues (2001) Biochimie, 83 (9 SEPTEMBER), pp. 851-862
• Cardenas Delgado, V.M., Nugnes, L.G., Colombo, L.L., Troncoso, M.F., Fernandez, M.M., Malchiodi, E.L., Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8 (2011) FASEB Journal, 25 (1 SEPTEMBER), pp. 242-254
• Imaizumi, T., Kumagai, M., Sasaki, N., Kurotaki, H., Mori, F., Seki, M., Interferon-{gamma} stimulates the expression of galectin-9 in cultured human endothelial cells (2002) Journal of Leukocyte Biology, 72 (3 SEPTEMBER), pp. 486-491
• Thijssen, V.L., Hulsmans, S., Griffioen, A.W., The galectin profile of the endothelium; altered expression and localization in activated and tumor endothelial cells (2008) American Journal of Pathology, 172 (2), pp. 545-553
• Lotan, R., Belloni, P.N., Tressler, R.J., Lotan, D., Xu, X.C., Nicolson, G.L., Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion (1994) Glycoconjugate Journal, 11 (5 OCTOBER), pp. 462-468
• Clausse, N., van den Brule, F., Waltregny, D., Garnier, F., Castronovo, V., Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion (1999) Angiogenesis, 3 (4), pp. 317-325
• La, M., Cao, T.V., Cerchiaro, G., Chilton, K., Hirabayashi, J., Kasai, K., A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation (2003) American Journal of Pathology, 163 (4 OCTOBER), pp. 1505-1515
• Fukushi, J., Makagiansar, I.T., Stallcup, W.B., NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin (2004) Molecular Biology of the Cell, 15 (8 AUGUST), pp. 3580-3590
• Gil, C.D., La, M., Perretti, M., Oliani, S.M., Interaction of human neutrophils with endothelial cells regulates the expression of endogenous proteins annexin 1, galectin-1 and galectin-3 (2006) Cell Biology International, 30 (4 MARCH), pp. 338-344
• Yang, E., Shim, J.S., Woo, H.J., Kim, K.W., Kwon, H.J., Aminopeptidase N/CD13 induces angiogenesis through interaction with a pro-angiogenic protein, galectin-3 (2007) Biochemical and Biophysical Research Communications, 363 (2 NOVEMBER), pp. 336-341
• Alam, S., Li, H., Margariti, A., Martin, D., Zampetaki, A., Habi, O., Galectin-9 protein expression in endothelial cells is positively regulated by histone deacetylase 3 (2011) Journal of Biological Chemistry, 286 (51 DECEMBER), pp. 44211-44217
• Hirashima, M., Kashio, Y., Nishi, N., Yamauchi, A., Imaizumi, T.A., Kageshita, T., Galectin-9 in physiological and pathological conditions (2004) Glycoconjugate Journal, 19 (7-9), pp. 593-600
• Imaizumi, T., Yoshida, H., Nishi, N., Sashinami, H., Nakamura, T., Hirashima, M., Double-stranded RNA induces galectin-9 in vascular endothelial cells: involvement of TLR3, PI3K, and IRF3 pathway (2007) Glycobiology, 17 (7 JULY), pp. 12C-15C
• Imaizumi, T., Kumagai, M., Nishi, N., Hirashima, M., Hatakeyama, M., Tamo, W., 15-deoxy-delta(12,14)-prostaglandin J2 inhibits ifn-gamma-induced galectin-9 expression in cultured human umbilical vein endothelial cells (2003) International Archives of Allergy and Immunology, 131 (1 MAY), pp. 57-61
• Bi, S., Earl, L.A., Jacobs, L., Baum, L.G., Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways (2008) Journal of Biological Chemistry, 283 (18 MAY), pp. 12248-12258
• Nishi, N., Itoh, A., Fujiyama, A., Yoshida, N., Araya, S., Hirashima, M., Development of highly stable galectins: truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins (2005) FEBS Letters, 579 (10 APRIL), pp. 2058-2064
• Asakura, H., Kashio, Y., Nakamura, K., Seki, M., Dai, S., Shirato, Y., Selective eosinophil adhesion to fibroblast via ifn-gamma-induced galectin-9 (2002) Journal of Immunology, 169 (10 NOVEMBER), pp. 5912-5918
• Chabot, S., Kashio, Y., Seki, M., Shirato, Y., Nakamura, K., Nishi, N., Regulation of galectin-9 expression and release in jurkat T cell line cells (2002) Glycobiology, 12 (2 FEBRUARY), pp. 111-118
• Lipkowitz, M.S., Leal-Pinto, E., Cohen, B.E., Abramson, R.G., Galectin 9 is the sugar-regulated urate transporter/channel UAT (2004) Glycoconjugate Journal, 19 (7-9), pp. 491-498
• Garcia-Cardena, G., Comander, J., Anderson, K.R., Blackman, B.R., Gimbrone, M.A.J., Biomechanical activation of vascular endothelium as a determinant of its functional phenotype (2001) Proceedings of the National Academy of Sciences of the United States of America, 98 (8 APRIL), pp. 4478-4485
• Glinskii, O.V., Turk, J.R., Pienta, K.J., Huxley, V.H., Glinsky, V.V., Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells (2004) Journal of Physiology, 554 (JANUARY), pp. 89-99. , (Pt 1)
• Glinsky, V.V., Glinsky, G.V., Glinskii, O.V., Huxley, V.H., Turk, J.R., Mossine, V.V., Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium (2003) Cancer Research, 63 (13 JULY), pp. 3805-3811
• Le, Q.T., Shi, G., Cao, H., Nelson, D.W., Wang, Y., Chen, E.Y., Galectin-1: a link between tumor hypoxia and tumor immune privilege (2005) Journal of Clinical Oncology, 23 (35 DECEMBER), pp. 8932-8941
• Zhao, X.Y., Chen, T.T., Xia, L., Guo, M., Xu, Y., Yue, F., Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells (2010) Carcinogenesis, 31 (8 AUGUST), pp. 1367-1375
• Zhao, X.Y., Zhao, K.W., Jiang, Y., Zhao, M., Chen, G.Q., Synergistic induction of galectin-1 by C/EBP{alpha} and HIF-1{alpha} and its role in differentiation of acute myeloid leukemic cells (2011) Journal of Biological Chemistry, 286 (42 AUGUST), pp. 36808-36819
• Greijer, A.E., van der Groep, P., Kemming, D., Shvarts, A., Semenza, G.L., Meijer, G.A., Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1) (2005) Journal of Pathology, 206 (3 JULY), pp. 291-304
• Zeng, Y., Danielson, K.G., Albert, T.J., Shapiro, I.M., Risbud, M.V., HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc (2007) Journal of Bone and Mineral Research, 22 (12 DECEMBER), pp. 1851-1861
• Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., Disrupting galectin-1 interactions with n-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in kaposi's sarcoma (2012) Journal of Experimental Medicine, 209 (11 OCTOBER), pp. 1985-2000
• Baum, L.G., Pang, M., Perillo, N.L., Wu, T., Delegeane, A., Uittenbogaart, C.H., Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 o-glycans on thymocytes and T lymphoblastoid cells (1995) Journal of Experimental Medicine, 181 (3 MARCH), pp. 877-887
• He, J., Baum, L.G., Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits t-cell transendothelial migration (2006) Laboratory Investigation, 86 (6 JUNE), pp. 578-590
• Perillo, N.L., Pace, K.E., Seilhamer, J.J., Baum, L.G., Apoptosis of T cells mediated by galectin-1 (1995) Nature, 378 (6558 DECEMBER), pp. 736-739
• Rao, S.P., Wang, Z., Zuberi, R.I., Sikora, L., Bahaie, N.S., Zuraw, B.L., Galectin-3 functions as an adhesion molecule to support eosinophil rolling and adhesion under conditions of flow (2007) Journal of Immunology, 179 (11 DECEMBER), pp. 7800-7807
• Ahrens, I., Domeij, H., Topcic, D., Haviv, I., Merivirta, R.M., Agrotis, A., Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expression (2011) PLoS ONE, 6 (8), pp. e23210
• Deo, P., Glenn, J.V., Powell, L.A., Stitt, A.W., Ames, J.M., Upregulation of oxidative stress markers in human microvascular endothelial cells by complexes of serum albumin and digestion products of glycated casein (2009) Journal of Biochemical and Molecular Toxicology, 23 (5 SEPTEMBER), pp. 364-372
• Stitt, A.W., He, C., Vlassara, H., Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells (1999) Biochemical and Biophysical Research Communications, 256 (3 MARCH), pp. 549-556
• Garner, O.B., Aguilar, H.C., Fulcher, J.A., Levroney, E.L., Harrison, R., Wright, L., Endothelial galectin-1 binds to specific glycans on nipah virus fusion protein and inhibits maturation, mobility, and function to block syncytia formation (2010) PLoS Pathogens, 6 (7), pp. e1000993
• Ishikawa, A., Imaizumi, T., Yoshida, H., Nishi, N., Nakamura, T., Hirashima, M., Double-stranded RNA enhances the expression of galectin-9 in vascular endothelial cells (2004) Immunology and Cell Biology, 82 (4 AUGUST), pp. 410-414
• Warke, R.V., Xhaja, K., Martin, K.J., Fournier, M.F., Shaw, S.K., Brizuela, N., Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells (2003) Journal of Virology, 77 (21 NOVEMBER), pp. 11822-11832
• Hsieh, S.H., Ying, N.W., Wu, M.H., Chiang, W.F., Hsu, C.L., Wong, T.Y., Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells (2008) Oncogene, 27 (26), pp. 3746-3753
• Markowska, A.I., Jefferies, K.C., Panjwani, N., Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells (2011) Journal of Biological Chemistry, 286 (34 AUGUST), pp. 29913-29921
• D'Haene, N., Sauvage, S., Maris, C., Adanja, I., Le Mercier, M., Decaestecker, C., VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis (2013) PLoS ONE, 8 (6), pp. e67029
• Ito, K., Scott, S.A., Cutler, S., Dong, L.F., Neuzil, J., Blanchard, H., Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress (2011) Angiogenesis, 14 (3 SEPTEMBER), pp. 293-307
• Jouve, N., Despoix, N., Espeli, M., Gauthier, L., Cypowyj, S., Fallague, K., The involvement of CD146 and its novel ligand galectin-1 in apoptotic regulation of endothelial cells (2013) Journal of Biological Chemistry, 288 (4 JANUARY), pp. 2571-2579
• Yan, Y.P., Lang, B.T., Vemuganti, R., Dempsey, R.J., Galectin-3 mediates post-ischemic tissue remodeling (2009) Brain Research, 1288 (SEPTEMBER), pp. 116-124
• Markowska, A.I., Liu, F.T., Panjwani, N., Galectin-3 is an important mediator of VEGF- and bfgf-mediated angiogenic response (2010) Journal of Experimental Medicine, 207 (9 AUGUST), pp. 1981-1993
• Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K.J., Galectin-3 induces endothelial cell morphogenesis and angiogenesis (2000) American Journal of Pathology, 156 (3 MARCH), pp. 899-909
• Wesley, U.V., Vemuganti, R., Ayvaci, E.R., Dempsey, R.J., Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling (2013) Brain Research, 1496 (FEBRUARY), pp. 1-9
• Wan, S.Y., Zhang, T.F., Ding, Y., Galectin-3 enhances proliferation and angiogenesis of endothelial cells differentiated from bone marrow mesenchymal stem cells (2011) Transplantation Proceedings, 43 (10 DECEMBER), pp. 3933-3938
• Nangia-Makker, P., Hogan, V., Honjo, Y., Baccarini, S., Tait, L., Bresalier, R., Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin (2002) Journal of the National Cancer Institute, 94 (24 DECEMBER), pp. 1854-1862
• Nangia-Makker, P., Wang, Y., Raz, T., Tait, L., Balan, V., Hogan, V., Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer (2010) International Journal of Cancer, 127 (11 DECEMBER), pp. 2530-2541
• Balan, V., Nangia-Makker, P., Kho, D.H., Wang, Y., Raz, A., Tyrosine-phosphorylated galectin-3 protein is resistant to prostate-specific antigen (PSA) cleavage (2012) Journal of Biological Chemistry, 287 (8 FEBRUARY), pp. 5192-5198
• Hadari, Y.R., Arbel-Goren, R., Levy, Y., Amsterdam, A., Alon, R., Zakut, R., Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis (2000) Journal of Cell Science, 113 (13 JULY), pp. 2385-2397
• Diskin, S., Cao, Z., Leffler, H., Panjwani, N., The role of integrin glycosylation in galectin-8-mediated trabecular meshwork cell adhesion and spreading (2009) Glycobiology, 19 (1 JANUARY), pp. 29-37
• Poirier, F., Robertson, E.J., Normal development of mice carrying a null mutation in the gene encoding the L14 s-type lectin (1993) Development, 119 (4 DECEMBER), pp. 1229-1236
• Colnot, C., Fowlis, D., Ripoche, M.A., Bouchaert, I., Poirier, F., Embryonic implantation in galectin 1/galectin 3 double mutant mice (1998) Developmental Dynamics, 211 (4 APRIL), pp. 306-313
• Hsu, D.K., Yang, R.-Y., Pan, Z., Yu, L., Salomon, D.R., Fung-Leung, W.-P., Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses (2000) American Journal of Pathology, 156 (3), pp. 1073-1083
• Freitag, N., Tirado-González, I., Barrientos, G., Herse, F., Thijssen, V.L., Weedon-Fekjær, S.M., Interfering with gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia (2013) Proceedings of the National Academy of Sciences of the United States of America, (JUNE)
• Gao, X., Liu, D., Fan, Y., Li, X., Xue, H., Ma, Y., The two endocytic pathways mediated by the carbohydrate recognition domain and regulated by the collagen-like domain of galectin-3 in vascular endothelial cells (2012) PLoS ONE, 7 (12), pp. e52430
• Jia, J., Wang, J., Teh, M., Sun, W., Zhang, J., Kee, I., Identification of proteins differentially expressed between capillary endothelial cells of hepatocellular carcinoma and normal liver in an orthotopic rat tumor model using 2-D DIGE (2010) Proteomics, 10 (2 JANUARY), pp. 224-234
• Laderach, D.J., Gentilini, L.D., Giribaldi, L., Delgado, V.C., Nugnes, L., Croci, D.O., A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (2013) Cancer Research, 73 (1 JANUARY), pp. 86-96
• D'Haene, N., Catteau, X., Maris, C., Martin, B., Salmon, I., Decaestecker, C., Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas (2008) British Journal of Haematology, 40 (4 FEBRUARY), pp. 402-410
• Gordower, L., Decaestecker, C., Kacem, Y., Lemmers, A., Gusman, J., Burchert, M., Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis (1999) Neuropathology and Applied Neurobiology, 25 (4 AUGUST), pp. 319-330
• Strik, H.M., Deininger, M.H., Frank, B., Schluesener, H.J., Meyermann, R., Galectin-3: cellular distribution and correlation with who-grade in human gliomas (2001) Journal of Neuro-Oncology, 53 (1 MAY), pp. 13-20
• Deininger, M.H., Trautmann, K., Meyermann, R., Schluesener, H.J., Galectin-3 labeling correlates positively in tumor cells and negatively in endothelial cells with malignancy and poor prognosis in oligodendroglioma patients (2002) Anticancer Research, 22 (3 MAY), pp. 1585-1592
• Liu, F.T., Rabinovich, G.A., Galectins as modulators of tumour progression (2005) Nature Reviews Cancer, 5 (1 JANUARY), pp. 29-41
• Ito, K., Stannard, K., Gabutero, E., Clark, A.M., Neo, S.Y., Onturk, S., Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment (2012) Cancer and Metastasis Reviews, (JUNE)
• Braeuer, R.R., Shoshan, E., Kamiya, T., Bar-Eli, M., The sweet and bitter sides of galectins in melanoma progression (2012) Pigment Cell and Melanoma Research, 25 (5 SEPTEMBER), pp. 592-601
• Elad-Sfadia, G., Haklai, R., Ballan, E., Gabius, H.J., Kloog, Y., Galectin-1 augments ras activation and diverts ras signals to raf-1 at the expense of phosphoinositide 3-kinase (2002) Journal of Biological Chemistry, 277 (40 OCTOBER), pp. 37169-37175
• Elad-Sfadia, G., Haklai, R., Balan, E., Kloog, Y., Galectin-3 augments k-ras activation and triggers a ras signal that attenuates ERK but not phosphoinositide 3-kinase activity (2004) Journal of Biological Chemistry, 279 (33 AUGUST), pp. 34922-34930
• Hsu, D.K., Liu, F.T., Regulation of cellular homeostasis by galectins (2004) Glycoconjugate Journal, 19 (7-9), pp. 507-515
• Liu, F.T., Yang, R.Y., Saegusa, J., Chen, H.Y., Hsu, D.K., Galectins in regulation of apoptosis (2011) Advances in Experimental Medicine and Biology, 705, pp. 431-442
• Thijssen, V.L., Poirier, F., Baum, L.G., Griffioen, A.W., Galectins in the tumor endothelium; opportunities for combined cancer therapy (2007) Blood, 110 (8), pp. 2819-2827
• Le Mercier, M., Lefranc, F., Mijatovic, T., Debeir, O., Haibe-Kains, B., Bontempi, G., Evidence of galectin-1 involvement in glioma chemoresistance (2008) Toxicology and Applied Pharmacology, 229 (2 JUNE), pp. 172-183
• Wu, M.H., Hong, T.M., Cheng, H.W., Pan, S.H., Liang, Y.R., Hong, H.C., Galectin-1-Mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons (2009) Molecular Cancer Research: MCR, 7 (3 MARCH), pp. 311-318
• Eude-Le Parco, I., Gendronneau, G., Dang, T., Delacour, D., Thijssen, V.L., Edelmann, W., Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice (2009) Glycobiology, 19 (1 JANUARY), pp. 68-75
• Takenaka, Y., Fukumori, T., Raz, A., Galectin-3 and metastasis (2004) Glycoconjugate Journal, 19 (7-9), pp. 543-549
• Le Mercier, M., Fortin, S., Mathieu, V., Kiss, R., Lefranc, F., Galectins and gliomas (2010) Brain Pathology, 20 (1 JANUARY), pp. 17-27
• Newlaczyl, A.U., Yu, L.-G., Galectin-3 - a jack-of-all-trades in cancer (2011) Cancer Letters, 313 (2), pp. 123-128
• Banh, A., Zhang, J., Cao, H., Bouley, D.M., Kwok, S., Kong, C., Tumor galectin-1 mediates lung cancer growth and metastasis through regulation of t-cell apoptosis (2011) Cancer Research, 71 (13 MAY), pp. 4423-4431
• Dalotto-Moreno, T., Croci, D.O., Cerliani, J.P., Martinez-Allo, V.C., Dergan-Dylon, S., Méndez-Huergo, S.P., Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease (2013) Cancer Research, 73 (3 FEBRUARY), pp. 1107-1117
• Ilarregui, J.M., Bianco, G.A., Toscano, M.A., Rabinovich, G.A., The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders (2005) Annals of the Rheumatic Diseases, 64 (NOVEMBER), pp. iv96-iv103. , (Suppl. 4)
• Rubinstein, N., Ilarregui, J.M., Toscano, M.A., Rabinovich, G.A., The role of galectins in the initiation, amplification and resolution of the inflammatory response (2004) Tissue Antigens, 64 (1 JULY), pp. 1-12
• Ilarregui, J.M., Croci, D.O., Bianco, G.A., Toscano, M.A., Salatino, M., Vermeulen, M.E., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nature Immunology, 10 (9 SEPTEMBER), pp. 981-991
• Norling, L.V., Sampaio, A.L., Cooper, D., Perretti, M., Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking (2008) FASEB Journal, 22 (3 MARCH), pp. 682-690
• Fukumori, T., Takenaka, Y., Yoshii, T., Kim, H.R., Hogan, V., Inohara, H., CD29 and CD7 mediate galectin-3-induced type II t-cell apoptosis (2003) Cancer Research, 63 (23 DECEMBER), pp. 8302-8311
• Stillman, B.N., Hsu, D.K., Pang, M., Brewer, C.F., Johnson, P., Liu, F.T., Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death (2006) Journal of Immunology, 176 (2 JANUARY), pp. 778-789
• Yang, R.Y., Hsu, D.K., Liu, F.T., Expression of galectin-3 modulates t-cell growth and apoptosis (1996) Proceedings of the National Academy of Sciences of the United States of America, 93 (13 JUNE), pp. 6737-6742
• Demotte, N., Wieërs, G., Van Der Smissen, P., Moser, M., Schmidt, C., Thielemans, K., A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice (2010) Cancer Research, 70 (19 OCTOBER), pp. 7476-7488
• Toscano, M.A., Bianco, G.A., Ilarregui, J.M., Croci, D.O., Correale, J., Hernandez, J.D., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death (2007) Nature Immunology, 8 (8 AUGUST), pp. 825-834
• Bi, S., Hong, P.W., Lee, B., Baum, L.G., Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance t-cell migration and HIV entry (2011) Proceedings of the National Academy of Sciences, 108 (26 JUNE), pp. 10650-10655
• Sato, S., Ouellet, N., Pelletier, I., Simard, M., Rancourt, A., Bergeron, M.G., Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia (2002) Journal of Immunology, 168 (4 FEBRUARY), pp. 1813-1822
• Wu, M.H., Hong, H.C., Hong, T.M., Chiang, W.F., Jin, Y.T., Chen, Y.L., Targeting galectin-1 in carcinoma-associated fibroblasts inhibits oral squamous cell carcinoma metastasis by downregulating MCP-1/CCL2 expression (2011) Clinical Cancer Research, 17 (6 MARCH), pp. 1306-1316
• Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5 (3 MARCH), pp. 241-251
• Elola, M.T., Wolfenstein-Todel, C., Troncoso, P., Vasta, G.R., Rabinovich, G.A., Matricellular glycan-binding proteins linking cell adhesion, migration, and survival (2007) Cellular and Molecular Life Sciences, 64 (13 JULY), pp. 1679-1700. , Galectins:
• Glinsky, V.V., Huflejt, M.E., Glinsky, G.V., Deutscher, S.L., Quinn, T.P., Effects of thomsen-friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells (2000) Cancer Research, 60 (10 MAY), pp. 2584-2588
• Khaldoyanidi, S.K., Glinsky, V.V., Sikora, L., Glinskii, A.B., Mossine, V.V., Quinn, T.P., MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by thomsen-friedenreich antigen-galectin-3 interactions (2003) Journal of Biological Chemistry, 278 (6 FEBRUARY), pp. 4127-4134
• Glinsky, V.V., Glinsky, G.V., Rittenhouse-Olson, K., Huflejt, M.E., Glinskii, O.V., Deutscher, S.L., The role of thomsen-friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium (2001) Cancer Research, 61 (12 JUNE), pp. 4851-4857
• Yu, L.G., Andrews, N., Zhao, Q., McKean, D., Williams, J.F., Connor, L.J., Galectin-3 interaction with thomsen-friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell-endothelial adhesion (2006) Journal of Biological Chemistry, 282 (1 NOVEMBER), pp. 773-781
• Saitoh, O., Wang, W.C., Lotan, R., Fukuda, M., Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials (1992) Journal of Biological Chemistry, 267 (8 MARCH), pp. 5700-5711
• Elola, M.T., Capurro, M.I., Barrio, M.M., Coombs, P.J., Taylor, M.E., Drickamer, K., Lewis x antigen mediates adhesion of human breast carcinoma cells to activated endothelium. Possible involvement of the endothelial scavenger receptor c-type lectin (2007) Breast Cancer Research and Treatment, 101 (2 JANUARY), pp. 161-174
• Kuzbicki, L., Gajo, B., Chwirot, B.W., Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions (2006) Melanoma Research, 16 (3 JUNE), pp. 235-243
• Sarafian, V., Jadot, M., Foidart, J.M., Letesson, J.J., Van den Brule, F., Castronovo, V., Expression of lamp-1 and lamp-2 and their interactions with galectin-3 in human tumor cells (1998) International Journal of Cancer, 75 (1 JANUARY), pp. 105-111
• Lehr, J.E., Pienta, K.J., Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line (1998) Journal of the National Cancer Institute, 90 (2 JANUARY), pp. 118-123
• Griffioen, A.W., Molema, G., Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation (2000) Pharmacological Reviews, 52 (2 JUNE), pp. 237-268. , Angiogenesis:
• Gotink, K.J., Verheul, H.M., Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? (2010) Angiogenesis, 13 (1 MARCH), pp. 1-14
• Kerbel, R.S., Tumor angiogenesis (2008) New England Journal of Medicine, 358 (19 MAY), pp. 2039-2049
• Ellis, L.M., Hicklin, D.J., VEGF-targeted therapy: mechanisms of anti-tumour activity (2008) Nature Reviews Cancer, 8 (8 AUGUST), pp. 579-591
• Cederfur, C., Salomonsson, E., Nilsson, J., Halim, A., Oberg, C.T., Larson, G., Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins (2008) Glycobiology, 18 (5 MAY), pp. 384-394
• Delaine, T., Cumpstey, I., Ingrassia, L., Mercier, M.L., Okechukwu, P., Leffler, H., Galectin-Inhibitory thiodigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells (2008) Journal of Medicinal Chemistry, 51 (24 MARCH), pp. 8109-8114
• Mirandola, L., Yu, Y., Chui, K., Jenkins, M.R., Cobos, E., John, C.M., Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma (2011) PLoS ONE, 6 (7), pp. e21811
• John, C.M., Leffler, H., Kahl-Knutsson, B., Svensson, I., Jarvis, G.A., Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer (2003) Clinical Cancer Research, 9 (6 JUNE), pp. 2374-2383
• Salomonsson, E., Carlsson, M.C., Osla, V., Hendus-Altenburger, R., Kahl Knutson, B., Oberg, C.T., Mutational tuning of galectin-3 specificity and biological function (2010) Journal of Biological Chemistry, 285 (45 AUGUST), pp. 35079-35091
• Griffioen, A.W., van der Schaft, D.W., Barendsz-Janson, A.F., Cox, A., Struijker Boudier, H.A., Hillen, H.F., Anginex, a designed peptide that inhibits angiogenesis (2001) Biochemical Journal, 354 (MARCH), pp. 233-242. , (Pt 2)
• van der Schaft, D.W., Dings, R.P., de Lussanet, Q.G., van Eijk, L.I., Nap, A.W., Beets-Tan, R.G., The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models (2002) FASEB Journal, 16 (14 DECEMBER), pp. 1991-1993
• Dings, R.P., Chen, X., Hellebrekers, D.M., van Eijk, L.I., Zhang, Y., Hoye, T.R., Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities (2006) Journal of the National Cancer Institute, 98 (13 JULY), pp. 932-936
• Dings, R.P., Kumar, N., Miller, M.C., Loren, M., Rangwala, H., Hoye, T.R., Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1 (2013) Journal of Pharmacology and Experimental Therapeutics, 344 (3 MARCH), pp. 589-599
• Salomonsson, E., Thijssen, V.L., Griffioen, A.W., Nilsson, U.J., Leffler, H., The anti-angiogenic peptide anginex greatly enhances galectin-1 binding affinity for glycoproteins (2011) Journal of Biological Chemistry, 286 (16 APRIL), pp. 13801-13804
• Ito, K., Ralph, S.J., Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence (2012) Clinical and Experimental Metastasis, 29 (6 APRIL), pp. 561-572
• Pienta, K.J., Naik, H., Akhtar, A., Yamazaki, K., Replogle, T.S., Lehr, J., Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin (1995) Journal of the National Cancer Institute, 87 (5 MARCH), pp. 348-353
• Glinskii, O.V., Huxley, V.H., Glinsky, G.V., Pienta, K.J., Raz, A., Glinsky, V.V., Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs (2005) Neoplasia, 7 (5 MAY), pp. 522-527
• Lavi, I., Levinson, D., Peri, I., Tekoah, Y., Hadar, Y., Schwartz, B., Chemical characterization, antiproliferative and antiadhesive properties of polysaccharides extracted from pleurotus pulmonarius mycelium and fruiting bodies (2010) Applied Microbiology and Biotechnology, 85 (6 FEBRUARY), pp. 1977-1990
• Zou, J., Glinsky, V.V., Landon, L.A., Matthews, L., Deutscher, S.L., Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion (2005) Carcinogenesis, 26 (2 FEBRUARY), pp. 309-318
• Glinskii, O.V., Sud, S., Mossine, V.V., Mawhinney, T.P., Anthony, D.C., Glinsky, G.V., Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-l-leucine (2012) Neoplasia, 14 (1 JANUARY), pp. 65-73
• Dings, R.P., Van Laar, E.S., Loren, M., Webber, J., Zhang, Y., Waters, S.J., Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6-hydroxylpropylacylfulvene (2010) Bioconjugate Chemistry, 21 (1 JANUARY), pp. 20-27
• Kluza, E., Jacobs, I., Hectors, S.J., Mayo, K.H., Griffioen, A.W., Strijkers, G.J., Dual-targeting of αvβ3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo (2012) Journal of Controlled Release, 158 (2 MARCH), pp. 207-214
• Brandwijk, R.J., Mulder, W.J., Nicolay, K., Mayo, K.H., Thijssen, V.L., Griffioen, A.W., Anginex-conjugated liposomes for targeting of angiogenic endothelial cells (2007) Bioconjugate Chemistry, 18 (3 MAY), pp. 785-790
• Brandwijk, R.J., Griffioen, A.W., Thijssen, V.L., Targeted gene-delivery strategies for angiostatic cancer treatment (2007) Trends in Molecular Medicine, 13 (5 MAY), pp. 200-209

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------